Statistics

Total Visits

Views
Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study66

Select a period of time:

Number of views in the range

Views
Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study31

Views

Views
January 20254
February 20255
March 202514
April 20255
May 20250
June 20253
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States13
Argentina1
Spain1
Hong Kong1
 

Top cities views

Views
Council Bluffs1
Hong Kong1